Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Temporary hair shedding after minoxidil use may indicate effective treatment.

Combining treatments works best for early hair loss, while transplants are best for severe cases.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Low-dose oral minoxidil does not significantly change alcohol consumption.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Baricitinib is effective and safe for treating severe alopecia areata.

PRP therapy is more effective and preferred over minoxidil for hair loss.

Baricitinib is effective and safe for treating severe alopecia areata.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

QR678 Neo is more effective than PRP for hair growth and quality.

Start low-dose minoxidil gradually, especially for women, to reduce side effects.

Baricitinib is effective for severe alopecia areata but has some side effects.

Systemic minoxidil is generally safe for older adults, but caution is needed for those with heart risks.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

Generic topical and transdermal systems usually cause minimal irritation or sensitization.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Finasteride and dutasteride do not significantly change beard thickness in men.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Blood count parameters are not reliable for predicting recurrent implantation failure.

Hair transplants are better for severe hair loss, while scalp micropigmentation suits those with denser hair.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.